A Network Intervention for Prevention of HIV Infection in Chennai, India - 1

This study has been completed.
Johns Hopkins University
Information provided by:
Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
First received: September 16, 2005
Last updated: March 7, 2011
Last verified: March 2011

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners in Chennai India.

Condition Intervention Phase
HIV Infections
Behavioral: psychoeducational
Behavioral: control
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Supplement to the Long-term Impact of a Network Outreach Intervention

Resource links provided by NLM:

Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:
  • needle sharing [ Time Frame: 3 month ] [ Designated as safety issue: No ]
  • condom use [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: January 2003
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Behavioral: psychoeducational
Active Comparator: 2
Behavioral: control

Detailed Description:

The intervention to be tested in this study draws upon theoretical and empirical evidence suggesting that peer educator programs can have significant effects on the risk-related behaviors of both the educators and the peers whom they educate. Specifically, through group and individual focused sessions, participants learn and practice skills designed to reduce drug and sex related risk behaviors. Furthermore, individuals and their main risk partners attend a training session that focuses on risk reduction within their relationship.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • drug users
  • network members
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218686

YRG Care
Chennai, Tamil Nadu, India, 600 113
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
Principal Investigator: Carl Latkin, Ph.D. Johns Hopkins University
  More Information

No publications provided

Responsible Party: Carl Latkin, JHU
ClinicalTrials.gov Identifier: NCT00218686     History of Changes
Other Study ID Numbers: DESPR DA013142, R01-13142-1, NIDA-13142-1
Study First Received: September 16, 2005
Last Updated: March 7, 2011
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
RNA Virus Infections
Retroviridae Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Virus Diseases

ClinicalTrials.gov processed this record on March 31, 2015